当前位置: 首页 >> 检索结果
共有 21077 条符合本次的查询结果, 用时 1.6046927 秒

1. Comment on: Fcgamma-receptor-activation by circulating immune complexes in systemic autoimmune diseases and its reduction by CD19-CAR T-cell therapy.

作者: Ranjeet Singh Mahla.
来源: Rheumatology (Oxford). 2026年

2. Menstruation in adolescents with Familial Mediterranean Fever: attack trigger or dysmenorrhea? A prospective cross-sectional study.

作者: Feray Kaya.;Elif Kucuk.;Lutfiye Koru.;Zelal Aydin.;Eda Nur Dizman.;Hatice Kubra Dursun.;Merve Ozen Balci.;Ufuk Furkan Ozturk.;Serpil Meric.;Deniz Dereli.;Fatih Haslak.;Kubra Ozturk.
来源: Rheumatology (Oxford). 2026年
This study investigated the relationship between menstruation and Familial Mediterranean Fever (FMF) attacks in adolescents and whether menstrual symptoms indicate true FMF flares or primary dysmenorrhea (PD) or premenstrual syndrome (PMS).

3. Diarrhea events in offspring exposed to tumour necrosis factor inhibitors and rotavirus vaccine: a population-based cohort study.

作者: Leah K Flatman.;Marie-Eve Beauchamp.;Yvan St-Pierre.;Isabelle Malhamé.;Anick Bérard.;Sasha Bernatsky.;Évelyne Vinet.
来源: Rheumatology (Oxford). 2026年
Previously, tumour necrosis factor inhibitors (TNFi)-exposed infants were recommended to withhold rotavirus vaccination until 6 months due to infection risk. Guidelines have recently supported earlier vaccination, although safety data remain limited. We aimed to compare diarrhea risk (during early [1.5-6 months] and later [6-24 months] infancy) in TNFi-exposed infants who received rotavirus vaccination before 6 months vs those unvaccinated by 6 months.

4. Cluster-defined gout subtypes exhibit divergent chronic kidney disease trajectories: a machine learning approach in a Chinese prospective cohort.

作者: Shuhui Hu.;Lingling Cui.;Ying Chen.;Xinde Li.;Can Wang.;Yulei Zhao.;Yiru Zhang.;Robert Terkeltaub.;Changgui Li.;Jie Lu.
来源: Rheumatology (Oxford). 2026年
To systematically evaluate the contribution of clinical heterogeneity to chronic kidney disease (CKD) progression in gout patients using data-driven phenotyping, and to assess whether incorporating genetic risk improves prediction of renal outcomes.

5. Serum ICAM-1 and VCAM-1 as markers of endothelial activation in ankylosing spondylitis and psoriatic arthritis: a cross-sectional study.

作者: Miroslav Markov.;Maria Dimova.;Simona Bogdanova.;Trifon Chervenkov.;Tsvetoslav Georgiev.
来源: BMC Rheumatol. 2026年
Patients with ankylosing spondylitis (AS) and psoriatic arthritis (PsA) have increased cardiovascular risk beyond traditional factors. Endothelial activation is an early and potentially reversible stage of atherogenesis, and circulating adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) have been proposed as markers of vascular involvement in inflammatory diseases. This study aimed to compare serum ICAM-1 and VCAM-1 levels in patients with ankylosing spondylitis and psoriatic arthritis versus controls, and to examine their associations with disease activity, systemic inflammatory burden, cardiovascular risk profile, and treatment status.

6. Lactylation of SOD1 promotes oxidative damage in IVDD.

作者: Jessica McHugh.
来源: Nat Rev Rheumatol. 2026年

8. Factors associated with anakinra effectiveness and risk of infection in crystal-related flares.

作者: Camille Moriot.;Pierre-Antoine Juge.;Sébastien Ottaviani.;Marine Forien.;Anna Molto.;Philippe Dieudé.;Esther Ebstein.
来源: Rheumatology (Oxford). 2026年
To assess the effectiveness and safety of anakinra in crystal-related disease (CRD) flares, and to identify factors associated with treatment failure and risk of infection.

9. Structural alterations in PPP1R13L, SAE1, ATP5A1 and PCK2 disrupt NF-κB signalling and mitochondrial metabolism in primary dermal fibroblasts in systemic sclerosis.

作者: Jingya Li.;Daniel Abegg.;Liliana Malinovska.;Michał Rudnik.;Oliver Distler.;Przemysław Błyszczuk.;Paola Picotti.;Gabriela Kania.
来源: Rheumatology (Oxford). 2026年
Systemic sclerosis (SSc) is a proteopathy with limited diagnostic and therapeutic options. This study aimed to uncover structural protein alterations in dermal fibroblasts from diffuse cutaneous (dc)SSc patients using a novel method: limited proteolysis-mass spectrometry (LiP-MS).

10. Takayasu arteritis in the clustering era: a new piece to the puzzle?

作者: Mariana Freitas de Aguiar.;Alexandre Wagner Silva de Souza.
来源: Rheumatology (Oxford). 2026年

11. Comment on: Effect of TNF inhibitors on risk of depression in patients with AS: a nationwide propensity score-matched cohort study: Reply.

作者: Oh Chan Kwon.;Hye Sun Lee.;Hye Jin Yang.;Min-Chan Park.
来源: Rheumatology (Oxford). 2026年

12. Comment on: Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using TriNetX research platform.

作者: Joshua Wang.
来源: Rheumatology (Oxford). 2026年

13. Spinal lesions in axial spondyloarthritis: longitudinal assessment of disease-related and degenerative changes.

作者: Halise Hande Gezer.
来源: Rheumatology (Oxford). 2026年

14. Baricitinib in moderate to severe rheumatoid arthritis: dose-dependent efficacy and safety in a randomized clinical trial in a developing country.

作者: Md Sadikul Islam.;Minhaj Rahim Choudhury.;Mohammad Abul Kalam Azad.;Md Abu Shahin.;Syed Atiqul Haq.;S M Zobair Hossain.;Nabil Amin Khan.;Md Atiqur Rahman.
来源: BMC Rheumatol. 2026年

15. Clinical, serological, and hemodynamic factors associated with poor outcomes in systemic lupus erythematosus-associated pulmonary arterial hypertension: a multicenter retrospective study from Korea.

作者: Ji-Hyoun Kang.;Jiyeol Yoon.;Jason Jungsik Song.;Hyo-Jin Choi.;Seokchan Hong.;Chan Hong Jeon.;Seung-Geun Lee.;Eun Bong Lee.;Sang-Hyon Kim.;Sung-Eun Choi.;Dong-Jin Park.;Shin-Seok Lee.
来源: Rheumatology (Oxford). 2026年
To identify factors associated with adverse outcomes in Korean patients with systemic lupus erythematosus-associated pulmonary arterial hypertension (SLE-PAH) confirmed by right heart catheterization (RHC).

16. Assessment of the use of biologic drugs in the treatment of primary antiphospholipid syndrome.

作者: Maryia Nikitsina.;Marta Ramírez Martín.;Carlota Navarro-Joven.;Silvia Piunno.;Luigi Zolio.;David A Isenberg.
来源: Rheumatology (Oxford). 2026年
To assess the clinical efficacy, safety, and immunological effects of biologic therapies in patients with primary antiphospholipid syndrome (pAPS) and catastrophic antiphospholipid syndrome (CAPS).

17. Cardioprotective mechanisms and effects of glucagon-like peptide-1 receptor agonists in autoimmune rheumatic diseases.

作者: Derin Karacabeyli.;Diane Lacaille.
来源: Rheumatology (Oxford). 2026年
Cardiovascular diseases are the leading cause of premature death in many autoimmune rheumatic diseases (ARDs). Landmark randomized controlled trials in diabetes and obesity have demonstrated that glucagon-like peptide-1 receptor agonists (GLP-1RAs) have cardiovascular-kidney-metabolic benefits. Observational studies assessing GLP-1RAs in ARDs, including rheumatoid arthritis and systemic lupus erythematosus, have found reductions in risk of cardiovascular events similar to those reported in broader populations. GLP-1RAs likely exert their cardioprotective effects through direct and indirect mechanisms. GLP-1RAs treat type 2 diabetes and obesity, two important cardiovascular risk factors. They lower lipid levels by mitigating post-prandial hyperlipidaemia and reduce blood pressure by dampening carotid body-mediated sympathetic excitation. GLP-1RAs have anti-atherogenic and anti-inflammatory effects in mice. They attenuate T cell-mediated inflammation directly by activating GLP-1 receptors on gut intraepithelial lymphocytes, and myeloid cell-mediated inflammation indirectly by activating central neuronal GLP-1 receptors. While knowledge gaps remain, existing evidence supports a cardioprotective role for GLP-1RAs in ARDs.

18. Humoral responses against high-density lipoprotein are linked to unfavorable lipid and proteomic signatures in primary Sjögren disease-a multi-platform approach.

作者: Silvia Suárez-Díaz.;Daniel Miranda-Prieto.;Patricia López.;Alessia Alunno.;Ángel I Pérez-Álvarez.;Núria Amigó.;Aleida Martínez-Zapico.;Ana Suárez.;Javier Rodríguez-Carrio.
来源: Rheumatology (Oxford). 2026年
Immune-mediated mechanisms and altered lipid metabolism may contribute to increased cardiovascular risk in Sjögren disease (SjD). Antibodies targeting HDL have emerged as modulators of lipid dysfunction and inflammation in several rheumatic diseases, but their relevance in SjD remains unexplored. We aimed to characterize humoral responses against HDL in SjD and their associations with lipoprotein/lipid traits, inflammatory and proteomic features, and atherosclerosis.

19. Zumba Gold dance compared to conventional balance exercises as a proposed approach to improving balance and reducing the risk of falls in older adults.

作者: Teresa Sadura-Sieklucka.;Beata Sokołowska.;Joanna Anita Sikora.;Ewa Kądalska.;Ewa Sokołowska.;Tomasz Targowski.
来源: Reumatologia. 2026年64卷1期36-45页
The aging population is growing worldwide, and according to a 2015 World Health Organization report, the number of seniors over the age of 65 will be as high as 1.6 billion in 2050, representing 16.7% of the world's population. Moreover, the number of falls among people aged ≥ 65 is expected to increase by 47% by 2050, since coordination and balance, both static and dynamic, have a huge impact on the incidence of falls in seniors. This study was designed to determine whether there are differences in the effectiveness of Zumba Gold (ZG) dance training and conventional balance exercises (BE) in the context of static and dynamic balance and whether ZG may reduce the risk of falls in older adults.

20. Evaluating skin biopsy findings in fibromyalgia: a systematic review.

作者: Natalia Bejm.;Katarzyna Gruszecka.
来源: Reumatologia. 2026年64卷1期52-58页
Fibromyalgia syndrome (FMS) is a condition characterized by widespread musculoskeletal pain, often involving a neuropathic component. While pathophysiology remains vague, increasing evidence suggests that small fiber pathology (SFP) may be present in a significant subset of patients, indicating a peripheral nervous system contribution. This systematic review aims to evaluate the utility of skin biopsy as a diagnostic tool for patients with FMS, with special focus on SFP. A comprehensive database search was conducted to identify studies assessing intraepidermal nerve fiber density (IENFD) via skin biopsy in individuals diagnosed with FMS. The included studies demonstrated a reduction in IENFD in a substantial proportion of FMS patients, with reported prevalence ranging widely from 30% to over 85%. Small fiber pathology occurs in a significant proportion of individuals with FMS. Skin biopsy emerges as a valuable diagnostic tool. Further research is needed to better understand the underlying mechanism of SFP in FMS.
共有 21077 条符合本次的查询结果, 用时 1.6046927 秒